METHOD AND APPARATUS FOR DIAGNOSING FAILURES IN AN INTEGRATED CIRCUIT USING DESIGNFOR-DEBUG (DFD) TECHNIQUES

Details for Australian Patent Application No. 2002243849 (hide)

Owner SYNTEST TECHNOLOGIES, INC.

Inventors WANG, Laung-Terny; CHANG, MingTung; LIN, Shyh-Horng; CHAO, HaoJan; LEE, Jachee; WANG, Hsin-Po; WEN, Xiaoqing; HSU, Po-Ching; KAO, Shih-Chia; LIN, Meng-Chyi; TSAI, SenWei; HSU, Chi-Chan

Pub. Number AU-A-2002243849

PCT Pub. Number WO2002/071567

Priority 60/272,064 01.03.01 US; 10/086,214 27.02.02 US

Filing date 28 February 2002

Wipo publication date 19 September 2002

International Classifications

H02H 003/05 Emergency protective circuit arrangements for automatic disconnection directly responsive to an undesired change from normal electric working condition, with or without subsequent reconnection - with means for increasing reliability, e.g. redundancy arrangements

H03K 019/003 Logic circuits, i.e. having at least two inputs acting on one output - Modifications for increasing the reliability

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002243849

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002243850-METHOD FOR DETERMINING CONCENTRATION OF AN ANALYTE IN A TEST STRIP

2002243848-SUBSTITUTED QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS